Score Overview
Explore the 2021 public Archive ranking →
Where Fresenius Medical Care Corporation has ranked, year by year
Showing 10 years ranking history by HDB Score.
Reached the top 50 on HDB Score in 5 years, the longest run being 4 in a row — but not in 2021.
- FMS
2008: 32.1% · 2021: 20.7% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-28 | $ 22.95 | — |
1 Year2025-09-26 | $ 24.59 | -6.66% |
5 Years2021-09-28 | $ 30.62 | -25.04% |
10 Years2016-09-28 | $ 35.27 | -34.94% |
20 Years2006-09-28 | $ 15.17 | 51.26% |
30 Years1996-09-27 | $ 7.13 | 222.01% |
All Time1996-09-19 | $ 6.82 | 236.48% |
| Period | Last Price2026-09-28 | 1 Year2025-09-26 | 5 Years2021-09-28 | 10 Years2016-09-28 | 20 Years2006-09-28 | 30 Years1996-09-27 | All Time1996-09-19 |
|---|---|---|---|---|---|---|---|
| Price | $ 22.95 | $ 24.59 | $ 30.62 | $ 35.27 | $ 15.17 | $ 7.13 | $ 6.82 |
| Return | — | -6.66% | -25.04% | -34.94% | 51.26% | 222.01% | 236.48% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in EUR
| Year | |||
|---|---|---|---|
| TTM | € 19.50B | € 941M | |
| 2025 | € 19.62B | € 978M | € 1.59B |
| 2024 | € 19.33B | € 537M | € 1.34B |
| 2023 | € 19.45B | € 498M | € 1.55B |
| 2022 | € 19.39B | € 673M | € 1.46B |
| 2021 | € 17.61B | € 969M | € 1.64B |
| 2020 | € 17.85B | € 1.16B | € 1.24B |
| 2019 | € 17.47B | € 1.19B | € 1.16B |
| 2018 | € 16.54B | € 1.98B | € 2.26B |
| 2017 | € 17.78B | € 1.28B | € 993M |
| 2016 | € 17.03B | € 1.18B | € 974M |
| 2015 | € 15.30B | € 941M | € 751M |
| 2014 | € 13.01B | € 859M | € 678M |
| 2013 | € 10.58B | € 803M | € 530M |
| 2012 | € 10.43B | € 897M | € 520M |
| 2011 | € 9.87B | € 826M | € 352M |
| 2010 | € 9.06B | € 735M | € 393M |
| 2009 | € 7.85B | € 621M | € 210M |
| 2008 | € 7.62B | € 587M | € 159M |
| 2007 | € 6.66B | € 491M | € 167M |
| 2006 | € 6.43B | € 406M | € 120M |
| 2005 | € 5.71B | € 384M | € 71M |
| 2004 | € 4.59B | € 296M | € 43M |
| 2003 | € 4.38B | € 262M | € 38M |
| 2002 | € 4.84B | € 276M | € 61M |
| 2001 | € 5.46B | € 71M | € 69M |
| 2000 | € 4.47B | € 225M | € 68M |
| 1999 | € 3.81B | -€ 247M | € 34M |
| 1998 | € 2.98B | € 16M | € 27M |
| 1997 | € 2.96B | € 81M |
Fresenius Medical Care Corporation fundamental performance
Between 2020 and 2025, revenue grew from € 17.85B to € 19.62B and net income declined from € 1.16B to € 978M. Revenue increased in 3 of those 5 years; net income in 2.
Across Fresenius Medical Care Corporation's full reported history, from 1997 to 2025, revenue grew from € 2.96B to € 19.62B and net income grew from € 81M to € 978M. Revenue increased in 79% of the years measured; net income in 62%.
Fresenius Medical Care Corporation currently holds a 20-year HDB Score of 5.5 out of 10. How the HDB Score is calculated.
Membership
Continue FMS’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,816 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
